Third Quarter Fiscal 2024 vs. Third Quarter Fiscal 2023
● | Net Revenues of |
● | Gross profit margin of approximately 30.3% compared to 32.4% |
● | Adjusted EBITDA of |
● | Net loss of |
● | Diluted EPS of ( |
● | Adjusted EPS of |
GunBroker.com “Marketplace” Metrics – Third Quarter 2024
● | Marketplace revenue of approximately |
● | New user growth averaged approximately 37,000 per month |
● | Average take rate increased to 5.9% compared to 5.7% in fiscal 2023 |
“We continue to see increasing demand as the ammunition and firearms market recovers from 2022 and 2023’s post pandemic slump. As we look at opportunities going into fiscal 2025, we will focus on the transformation of our marketplace platform. We will also continue to transition our manufacturing model to one of pursuing higher margin, premium rifle and pistol ammunition opportunities as well as embracing the growing OEM brass business.,”
Third Quarter 2024 Results
We experienced an improvement in the marginality of our ammunition segment while the margins of the GunBroker.com marketplace segment remain strong. We continue to see positive demand trends building for our ammunition product and activity continues to increase on GunBoker.com as we enter into the final quarter of our fiscal year.
We ended the third quarter with total revenues of approximately
Cost of goods sold was approximately
Our gross margin for the quarter was
Our cost cutting measures are paying off, there was a 5.4% decrease in operating expenses as a percentage of sales from the prior year quarter adjusted to exclude nonrecurring expenses.
There were approximately
For the quarter, we recorded Adjusted EBITDA of approximately
This resulted in a net loss per share of (
Our improvements to our marketplace, GunBroker.com, continue as our cart platform is on schedule to launch on
We repurchased approximately 145,000 shares of our common stock under our repurchase plan in the reported quarter bringing us to just over 1.3 million shares repurchased in total under the plan since repurchases began in
Conference Call
Management will host a conference call at
Participants are asked to preregister for the call at the following link: https://dpregister.com/sreg/10185867/fb6f640d8c
Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-481-2698 (domestic) or 1-412-317-0655 (international).
Please join at least 5-10 minutes prior to the scheduled start and follow the operator’s instructions. When requested, please ask for “AMMO, Inc. Third Quarter 2024 Conference Call.”
The conference call will also be available through a live webcast at the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=mnSsDVht, which is also available through the Company’s website.
About
With its corporate offices headquartered in
About GunBroker.com
GunBroker.com is the largest online marketplace dedicated to firearms, hunting, shooting and related products. Aside from merchandise bearing its logo, GunBroker.com currently sells none of the items listed on its website. Third-party sellers list items on the site and Federal and state laws govern the sale of firearms and other restricted items. Ownership policies and regulations are followed using licensed firearms dealers as transfer agents. Launched in 1999, GunBroker.com is an informative, secure and safe way to buy and sell firearms, ammunition, air guns, archery equipment, knives and swords, firearms accessories and hunting/shooting gear online. GunBroker.com promotes responsible ownership of guns and firearms. For more information, please visit: www.gunbroker.com.
Forward Looking Statements
This document contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies, goals and objectives of management for future operations; any statements concerning proposed new products and services or developments thereof; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.
Forward looking statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words, or the negative thereof. These forward-looking statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however, consult further disclosures and risk factors we include in Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports filed on Form 8-K.
Investor Contact:
CoreIR
Phone: (212) 655-0924
IR@ammo-inc.com
Source: AMMO, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited) | ||||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 54,679,868 | $ | 39,134,027 | ||||
Accounts receivable, net | 21,121,450 | 29,346,380 | ||||||
Inventories | 49,502,732 | 54,344,819 | ||||||
Prepaid expenses | 3,708,865 | 5,126,667 | ||||||
Current portion of restricted cash | - | 500,000 | ||||||
Total Current Assets | 129,012,915 | 128,451,893 | ||||||
Equipment, net | 57,278,603 | 55,963,255 | ||||||
Other Assets: | ||||||||
Deposits | 2,265,932 | 7,028,947 | ||||||
Patents, net | 4,662,656 | 5,032,754 | ||||||
Other intangible assets, net | 114,296,627 | 123,726,810 | ||||||
90,870,094 | 90,870,094 | |||||||
Right of use assets - operating leases | 2,113,943 | 1,261,634 | ||||||
Deferred income tax asset | 115,908 | - | ||||||
TOTAL ASSETS | $ | 400,616,678 | $ | 412,335,387 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 19,146,138 | $ | 18,079,397 | ||||
Accrued liabilities | 6,570,668 | 4,353,354 | ||||||
Current portion of operating lease liability | 463,059 | 470,734 | ||||||
Note payable related party | - | 180,850 | ||||||
Current portion of construction note payable | 265,977 | 260,429 | ||||||
Insurance premium note payable | 173,029 | 2,118,635 | ||||||
Total Current Liabilities | 26,618,871 | 25,463,399 | ||||||
Long-term Liabilities: | ||||||||
Contingent consideration payable | 80,080 | 140,378 | ||||||
Construction note payable, net of unamortized issuance costs | 10,797,696 | 10,922,443 | ||||||
Operating lease liability, net of current portion | 1,737,615 | 903,490 | ||||||
Deferred income tax liability | - | 2,309,592 | ||||||
Total Liabilities | 39,234,262 | 39,739,302 | ||||||
Shareholders’ Equity: | ||||||||
Series A cumulative perpetual preferred Stock 8.75%, ( | 1,400 | 1,400 | ||||||
Common stock, | 118,644 | 118,294 | ||||||
Additional paid-in capital | 395,449,082 | 391,940,374 | ||||||
Accumulated deficit | (31,513,554 | ) | (18,941,825 | ) | ||||
Treasury Stock | (2,673,156 | ) | (522,158 | ) | ||||
Total Shareholders’ Equity | 361,382,416 | 372,596,085 | ||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | 400,616,678 | $ | 412,335,387 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net Revenues | ||||||||||||||||
Ammunition sales(1) | $ | 17,322,967 | $ | 20,250,965 | $ | 46,945,585 | $ | 90,607,817 | ||||||||
Marketplace revenue | 13,985,034 | 15,419,202 | 40,371,952 | 46,486,842 | ||||||||||||
Casing sales | 4,698,463 | 3,041,327 | 17,315,888 | 10,661,420 | ||||||||||||
36,006,464 | 38,711,494 | 104,633,425 | 147,756,079 | |||||||||||||
Cost of Revenues | 25,096,088 | 26,184,315 | 71,410,243 | 104,257,529 | ||||||||||||
Gross Profit | 10,910,376 | 12,527,179 | 33,223,182 | 43,498,550 | ||||||||||||
Operating Expenses | ||||||||||||||||
Selling and marketing | 236,565 | 1,010,543 | 822,098 | 3,987,214 | ||||||||||||
Corporate general and administrative | 5,803,255 | 7,835,201 | 21,606,442 | 17,920,197 | ||||||||||||
Employee salaries and related expenses | 3,390,153 | 4,705,636 | 13,096,468 | 11,414,434 | ||||||||||||
Depreciation and amortization expense | 3,401,156 | 3,309,074 | 10,117,001 | 9,950,752 | ||||||||||||
Total operating expenses | 12,831,129 | 16,860,454 | 45,642,009 | 43,272,597 | ||||||||||||
Income/(Loss) from Operations | (1,920,753 | ) | (4,333,275 | ) | (12,418,827 | ) | 225,953 | |||||||||
Other Expenses | ||||||||||||||||
Other income/(loss) | 4,576 | (170,403 | ) | 376,186 | 28,193 | |||||||||||
Interest expense | (193,046 | ) | (320,439 | ) | (609,561 | ) | (538,191 | ) | ||||||||
Total other expense, net | (188,470 | ) | (490,842 | ) | (233,375 | ) | (509,998 | ) | ||||||||
Loss before Income Taxes | (2,109,223 | ) | (4,824,117 | ) | (12,652,202 | ) | (284,045 | ) | ||||||||
Provision for Income Taxes | (465,234 | ) | (721,125 | ) | (2,419,883 | ) | 1,369,427 | |||||||||
Net Loss | (1,643,989 | ) | (4,102,992 | ) | (10,232,319 | ) | (1,653,472 | ) | ||||||||
Preferred Stock Dividend | (782,639 | ) | (782,639 | ) | (2,339,410 | ) | (2,339,409 | ) | ||||||||
Net Loss Attributable to Common Stock Shareholders | $ | (2,426,628 | ) | $ | (4,885,631 | ) | $ | (12,571,729 | ) | $ | (3,992,881 | ) | ||||
Net Loss per share | ||||||||||||||||
Basic | $ | (0.02 | ) | $ | (0.04 | ) | $ | (0.11 | ) | $ | (0.03 | ) | ||||
Diluted | $ | (0.02 | ) | $ | (0.04 | ) | $ | (0.11 | ) | $ | (0.03 | ) | ||||
Weighted average number of shares outstanding | ||||||||||||||||
Basic | 118,447,154 | 117,348,511 | 118,110,943 | 116,950,013 | ||||||||||||
Diluted | 118,447,154 | 117,348,511 | 118,110,943 | 116,950,013 |
(1 | ) | Included in revenue for the three months ended |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited)
For the Nine Months Ended | ||||||||
2023 | 2022 | |||||||
Cash flows from operating activities: | ||||||||
Net Loss | $ | (10,232,319 | ) | $ | (1,653,472 | ) | ||
Adjustments to reconcile Net Loss to | ||||||||
Depreciation and amortization | 14,047,216 | 12,950,972 | ||||||
Debt discount amortization | 62,440 | 62,440 | ||||||
Employee stock awards | 2,977,845 | 4,457,973 | ||||||
Stock grants | 152,250 | 135,344 | ||||||
Common stock purchase options | 380,045 | - | ||||||
Warrants Issued for Services | - | 106,909 | ||||||
Contingent consideration payable fair value | (60,298 | ) | (45,572 | ) | ||||
Allowance for doubtful accounts | 1,117,565 | 1,327,419 | ||||||
Reduction in right of use asset | 362,402 | 512,063 | ||||||
Deferred income taxes | (2,425,500 | ) | 1,283,481 | |||||
Changes in Current Assets and Liabilities | ||||||||
Accounts receivable | 7,107,365 | 12,208,054 | ||||||
Due from related parties | - | 15,000 | ||||||
Inventories | 4,842,087 | (8,129,249 | ) | |||||
Prepaid expenses | 2,474,001 | 1,941,206 | ||||||
Deposits | 4,763,015 | 1,678,415 | ||||||
Accounts payable | 1,066,741 | (5,852,397 | ) | |||||
Accrued liabilities | 2,072,696 | (2,044,248 | ) | |||||
Operating lease liability | (388,261 | ) | (522,917 | ) | ||||
Net cash provided by operating activities | 28,319,290 | 18,431,421 | ||||||
Cash flows from investing activities: | ||||||||
Purchase of equipment | (5,562,283 | ) | (10,566,182 | ) | ||||
Net cash used in investing activities | (5,562,283 | ) | (10,566,182 | ) | ||||
Cash flow from financing activities: | ||||||||
Proceeds from factoring liability | 37,252,869 | 57,300,000 | ||||||
Payments on factoring liability | (37,252,869 | ) | (56,107,221 | ) | ||||
Payments on inventory facility, net | - | (825,675 | ) | |||||
Payments on note payable - related party | (180,850 | ) | (507,508 | ) | ||||
Payments on insurance premium note payment | (3,001,805 | ) | (1,916,070 | ) | ||||
Proceeds from construction note payable | - | 1,000,000 | ||||||
Payments on construction note payable | (181,639 | ) | (66,586 | ) | ||||
Preferred stock dividends paid | (2,194,792 | ) | (2,195,075 | ) | ||||
Common stock repurchase plan | (2,152,080 | ) | (291,011 | ) | ||||
Common stock issued for exercised warrants | - | 56,046 | ||||||
Net cash used in financing activities | (7,711,166 | ) | (3,553,100 | ) | ||||
Net increase in cash | 15,045,841 | 4,312,139 | ||||||
Restricted cash, beginning of period | 500,000 | - | ||||||
Cash, beginning of period | 39,134,027 | 23,281,475 | ||||||
Cash and restricted cash, end of period | $ | 54,679,868 | $ | 27,593,614 | ||||
Restricted cash, end of period | $ | - | $ | 500,000 | ||||
Cash, end of period | $ | 54,679,868 | $ | 27,093,614 |
(Continued)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited)
For the Nine Months Ended | ||||||||
2023 | 2022 | |||||||
Supplemental cash flow disclosures: | ||||||||
Cash paid during the period for: | ||||||||
Interest | $ | 548,118 | $ | 433,761 | ||||
Income taxes | $ | - | $ | 1,302,811 | ||||
Non-cash investing and financing activities: | ||||||||
Operating lease liability | $ | 1,214,711 | $ | 901,076 | ||||
Insurance premium note payment | $ | 1,056,199 | $ | 2,035,519 | ||||
Dividends accumulated on preferred stock | $ | 144,618 | $ | 144,334 | ||||
Construction note payable | $ | - | $ | 10,237,032 | ||||
Warrants issued for services | $ | - | $ | 427,639 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Non-GAAP Financial Measures
We analyze operational and financial data to evaluate our business, allocate our resources, and assess our performance. In addition to total net sales, net loss, and other results under accounting principles generally accepted in
Reconciliation of GAAP net income to Adjusted EBITDA
Adjusted EBITDA
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
Reconciliation of GAAP net income to Adjusted EBITDA | ||||||||||||||||
Net Loss | $ | (1,643,989 | ) | $ | (4,102,992 | ) | $ | (10,232,319 | ) | $ | (1,653,472 | ) | ||||
Provision for Income Taxes | (465,234 | ) | (721,125 | ) | (2,419,883 | ) | 1,369,427 | |||||||||
Depreciation and amortization | 4,753,650 | 4,356,004 | 14,047,216 | 12,950,972 | ||||||||||||
Interest expense, net | 193,046 | 320,439 | 609,561 | 538,191 | ||||||||||||
Employee stock awards | 687,099 | 2,106,535 | 2,977,845 | 4,457,973 | ||||||||||||
Stock grants | 50,750 | 43,750 | 152,250 | 135,344 | ||||||||||||
Common stock purchase options | 380,045 | - | 380,045 | - | ||||||||||||
Warrant Issuance | - | 106,909 | - | 106,909 | ||||||||||||
Other (income) expense, net | (4,576 | ) | 170,403 | (376,186 | ) | (28,193 | ) | |||||||||
Contingent consideration fair value | (39,274 | ) | (20,326 | ) | (60,298 | ) | (45,572 | ) | ||||||||
Other nonrecurring expenses(1) | 1,498,684 | 3,983,254 | 8,126,102 | 4,724,385 | ||||||||||||
Adjusted EBITDA | $ | 5,410,201 | $ | 6,242,851 | $ | 13,204,333 | $ | 22,555,964 |
1 | ) | For the three and nine months ended |
Reconciliation of GAAP net income to Fully Diluted EPS
For the Three Months Ended | ||||||||||||||||
Reconciliation of GAAP net income to Fully Diluted EPS | ||||||||||||||||
Net Loss | $ | (1,643,989 | ) | $ | (0.01 | ) | $ | (4,102,992 | ) | $ | (0.03 | ) | ||||
Depreciation and amortization | 4,753,650 | 0.04 | 4,356,004 | 0.04 | ||||||||||||
Interest expense, net | 193,046 | - | 320,439 | - | ||||||||||||
Employee stock awards | 687,099 | 0.01 | 2,106,535 | 0.02 | ||||||||||||
Stock grants | 50,750 | - | 43,750 | - | ||||||||||||
Common stock purchase options | 380,045 | - | - | - | ||||||||||||
Warrant issuance | - | - | 106,909 | - | ||||||||||||
Contingent consideration fair value | (39,274 | ) | - | (20,326 | ) | - | ||||||||||
Nonrecurring expenses | 1,498,684 | 0.01 | 3,983,254 | 0.03 | ||||||||||||
Tax effect(1) | (1,708,026 | ) | (0.01 | ) | (2,294,820 | ) | (0.02 | ) | ||||||||
Adjusted Net Income | $ | 4,171,985 | $ | 0.04 | $ | 4,498,753 | $ | 0.04 |
For the Nine Months Ended | ||||||||||||||||
Reconciliation of GAAP net income to Fully Diluted EPS | ||||||||||||||||
Net Loss | $ | (10,232,319 | ) | $ | (0.09 | ) | $ | (1,653,472 | ) | $ | (0.01 | ) | ||||
Depreciation and amortization | 14,047,216 | 0.12 | 12,950,972 | 0.11 | ||||||||||||
Interest expense, net | 609,561 | - | 538,191 | - | ||||||||||||
Employee stock awards | 2,977,845 | 0.03 | 4,457,973 | 0.04 | ||||||||||||
Stock grants | 152,250 | - | 135,344 | - | ||||||||||||
Common stock purchase options | 380,045 | - | - | |||||||||||||
Warrant issuance | - | 106,909 | - | |||||||||||||
Contingent consideration fair value | (60,298 | ) | - | (45,572 | ) | - | ||||||||||
Nonrecurring expenses | 8,126,102 | 0.07 | 4,724,385 | 0.04 | ||||||||||||
Tax effect(1) | (6,037,463 | ) | (0.05 | ) | (4,826,590 | ) | (0.04 | ) | ||||||||
Adjusted Net Income | $ | 9,962,939 | $ | 0.08 | $ | 16,388,140 | $ | 0.14 |
(1 | ) | Tax effects are estimated by applying the statutory rate to each applicable Non-GAAP adjustment. |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Weighted average number of shares outstanding | ||||||||||||||||
Basic | 118,447,154 | 117,348,511 | 118,110,943 | 116,950,013 | ||||||||||||
Diluted | 118,447,154 | 117,348,511 | 118,110,943 | 116,950,013 |
Source:
2024 GlobeNewswire, Inc., source